These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39144828)

  • 1. Prospective comparison of
    Xiang F; Zhang Y; Tan X; Yan Y; Liu H; Ma W; Chen Y
    Front Oncol; 2024; 14():1428498. PubMed ID: 39144828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study.
    Qiu L; Wang Y; Liu H; Wang Q; Chen L; Liu L; Wang L; Feng Y; Chen Y
    Clin Nucl Med; 2023 Jun; 48(6):489-496. PubMed ID: 36976706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential utility of [
    Li Y; Deng L; Feng Y; Liu L; Lv F; Qiu L
    Eur Radiol; 2023 Dec; 33(12):9378-9389. PubMed ID: 37454338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the relative diagnostic performance of
    Deng J; Yang J; Wang Y; Liu G; Chen Y
    Front Oncol; 2024; 14():1364311. PubMed ID: 38585006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective intra-individual comparison of [
    Lawal IO; Mokoala KMG; Mahapane J; Kleyhans J; Meckel M; Vorster M; Ebenhan T; Rösch F; Sathekge MM
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):134-142. PubMed ID: 32424485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic accuracy of
    Daniels H; Gilbert R; Bonin L
    J Med Imaging Radiat Sci; 2023 Sep; 54(3):545-555. PubMed ID: 37211439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, biological characterization and preliminary human imaging studies of
    Wang Y; Wang Q; Chen Z; Yang J; Liu H; Peng D; Lei L; Liu L; Wang L; Xing N; Qiu L; Feng Y; Chen Y
    Front Oncol; 2022; 12():1027792. PubMed ID: 36591490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific membrane antigen PET versus [
    Wang Y; Qiu Y; Yan X
    Front Med (Lausanne); 2024; 11():1451565. PubMed ID: 39386742
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Guo R; Meng X; Wang F; Yu J; Xie Q; Zhao W; Zhu L; Kung HF; Yang Z; Li N
    Front Oncol; 2021; 11():766851. PubMed ID: 34900716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Comparison of the Imaging Value of 99m Tc-MDP Bone Scan and 68 Ga-FAPI-04 PET/CT in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.
    Xu T; Ding H; Fan D; Shu Q; Liu G; Zhang S; Chen Y
    Clin Nucl Med; 2023 Sep; 48(9):768-774. PubMed ID: 37351858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-individual comparison of
    Bénard F; Harsini S; Wilson D; Zukotynski K; Abikhzer G; Turcotte E; Cossette M; Metser U; Romsa J; Martin M; Mar C; Saad F; Soucy JP; Eigl BJ; Black P; Krauze A; Burrell S; Nichol A; Tardif JC
    Lancet Oncol; 2022 Dec; 23(12):1499-1507. PubMed ID: 36343655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
    Sahin E; Zincirkeser S; Akcan AB; Elboga U
    J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of (18)F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases.
    Yoon SH; Kim KS; Kang SY; Song HS; Jo KS; Choi BH; Lee SJ; Yoon JK; An YS
    Nucl Med Mol Imaging; 2013 Mar; 47(1):27-35. PubMed ID: 24895505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A; Mittra E; Dick DW; Gambhir SS
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-individual comparison of prostate-specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis.
    Shanmugasundaram R; Saad J; Heyworth A; Wong V; Pelecanos A; Arianayagam M; Canagasingham B; Ferguson R; Goolam AS; Khadra M; Kam J; Ko R; McCombie S; Varol C; Winter M; Mansberg R; Nguyen D; Bui C; Loh H; Le K; Roberts MJ
    BJU Int; 2024 Feb; 133 Suppl 3():25-32. PubMed ID: 37943964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[
    Sonni I; Minamimoto R; Baratto L; Gambhir SS; Loening AM; Vasanawala SS; Iagaru A
    Mol Imaging Biol; 2020 Apr; 22(2):397-406. PubMed ID: 31236756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
    Zhang L; Chen L; Xie Q; Zhang Y; Cheng L; Li H; Wang J
    BMC Med Imaging; 2015 Mar; 15():7. PubMed ID: 25885599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.